New Report Available: Delcath Systems, Inc. (DCTH) - Product Pipeline Analysis, 2013 Update
Delcath Systems, Inc. (Delcath) is a US-based development stage, specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic liver cancers. Delcath's patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloodstream. Its clinical trial product, the Delcath Percutaneous Hepatic Perfusion System (the Delcath PHP System), also known as Hepatic Chemosaturation therapy allows...
View full press release